ClinConnect ClinConnect Logo
Search / Trial NCT05674942

Urinary Tract Infection in Patients With Chronic Kidney Disease

Launched by ALEXANDRIA UNIVERSITY · Dec 29, 2022

Trial Information

Current as of July 22, 2025

Completed

Keywords

Urinary Tract Infection Chronic Kidney Disease Uti Ckd

ClinConnect Summary

Chronic kidney disease (CKD) patients are at higher risk of urinary tract infections (UTI), as CKD is a state of chronic inflammation, metabolic disturbance and impaired immunocompetence. Moreover, patient with CKD are usually of advanced age and suffer from other comorbidities such as diabetes, hypertension, obesity, and cardiovascular diseases, which also add to their risk of infection.

UTI comprises heterogeneous conditions ranging from mild cystitis, easily treated with oral antibiotics, to life-threatening sepsis and multiple organ failure.

There is scarce information about risk fact...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Males and non-pregnant females aged ≥ 18 years old
  • 2. Patients with CKD stages (G1 to G4)
  • 3. Patients diagnosed with UTI due to urine culture
  • Exclusion Criteria:
  • 1. Non-CKD patients
  • 2. pregnant females
  • 3. CKD patients on immunosuppressant agents
  • 4. ESRD patients on hemodialysis
  • 5. Patients with structural abnormalities which make them liable to frequent UTI

About Alexandria University

Alexandria University, a leading academic institution in Egypt, is dedicated to advancing medical research and improving healthcare outcomes through innovative clinical trials. With a strong emphasis on collaboration and interdisciplinary approaches, the university leverages its extensive resources and expertise to conduct rigorous studies that address pressing health challenges. By fostering partnerships with healthcare professionals, industry leaders, and regulatory bodies, Alexandria University aims to contribute to the global body of medical knowledge and enhance the quality of patient care through evidence-based findings.

Locations

Alexandria, , Egypt

Patients applied

0 patients applied

Trial Officials

mohamed mamdouh elsayed, MD

Principal Investigator

Lecturer of Nephrology & Internal Medicine, Faculty of medicine, Alexandria University

Mohammed Abdel Gawad

Study Chair

Nephrology Lecturer, School of Medicine, New Giza University (NGU), Giza, Egypt

Dalia Elzayat

Study Chair

Faculty of Pharmacy, Pharos University, Alexandria, Egypt

Reham Mekawy

Study Chair

Faculty of Pharmacy, Pharos University, Alexandria, Egypt

Salma Mahdy

Study Chair

Faculty of Pharmacy, Pharos University, Alexandria, Egypt

Salma Imam

Study Chair

Faculty of Pharmacy, Pharos University, Alexandria, Egypt

Hala Abo El-hassan

Study Chair

Faculty of Pharmacy, Pharos University, Alexandria, Egypt

Ramy Elwaraky

Study Chair

Department of Clinical Pharmacy, Kidney and Urology Center, Alexandria, Egypt

Engy Emam

Study Chair

Clinical Pharmacist, Alexandria Main University Hospital, Alexandria, Egypt

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials